Monash IVF Group Statistics

Total Valuation

Monash IVF Group has a market cap or net worth of AUD 440.29 million. The enterprise value is 569.08 million.

Market Cap	440.29M
Enterprise Value	569.08M

Important Dates

The next estimated earnings date is Thursday, November 21, 2024.

Earnings Date	Nov 21, 2024
Ex-Dividend Date	Sep 5, 2024

Share Statistics

Monash IVF Group has 389.63 million shares outstanding. The number of shares has decreased by -0.71% in one year.

Current Share Class	n/a
Shares Outstanding	389.63M
Shares Change (YoY)	-0.71%
Shares Change (QoQ)	-0.77%
Owned by Insiders (%)	6.46%
Owned by Institutions (%)	35.58%
Float	337.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	14.05
PS Ratio	1.73
PB Ratio	1.82
P/TBV Ratio	n/a
P/FCF Ratio	13.89
P/OCF Ratio	n/a
PEG Ratio	1.61

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 48.22, with an EV/FCF ratio of 17.95.

EV / Earnings	-87.19
EV / Sales	2.23
EV / EBITDA	48.22
EV / EBIT	n/a
EV / FCF	17.95

Financial Position

The company has a current ratio of 0.47, with a Debt / Equity ratio of 0.55.

Current Ratio	0.47
Quick Ratio	0.35
Debt / Equity	0.55
Debt / EBITDA	11.47
Debt / FCF	4.27
Interest Coverage	-0.85

Financial Efficiency

Return on equity (ROE) is -2.28% and return on invested capital (ROIC) is -0.76%.

Return on Equity (ROE)	-2.28%
Return on Assets (ROA)	-0.62%
Return on Capital (ROIC)	-0.76%
Revenue Per Employee	255,993
Profits Per Employee	-6,547
Employee Count	997
Asset Turnover	0.55
Inventory Turnover	23.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.40% in the last 52 weeks. The beta is 1.40, so Monash IVF Group's price volatility has been higher than the market average.

Beta (5Y)	1.40
52-Week Price Change	-12.40%
50-Day Moving Average	1.19
200-Day Moving Average	1.33
Relative Strength Index (RSI)	36.03
Average Volume (20 Days)	753,654

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Monash IVF Group had revenue of AUD 255.23 million and -6.53 million in losses. Loss per share was -0.02.

Revenue	255.23M
Gross Profit	85.77M
Operating Income	-4.58M
Pretax Income	-10.66M
Net Income	-6.53M
EBITDA	2.09M
EBIT	-4.58M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 11.33 million in cash and 135.37 million in debt, giving a net cash position of -124.04 million or -0.32 per share.

Cash & Cash Equivalents	11.33M
Total Debt	135.37M
Net Cash	-124.04M
Net Cash Per Share	-0.32
Equity (Book Value)	246.66M
Book Value Per Share	0.62
Working Capital	-63.04M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 52.52 million and capital expenditures -20.82 million, giving a free cash flow of 31.70 million.

Operating Cash Flow	52.52M
Capital Expenditures	-20.82M
Free Cash Flow	31.70M
FCF Per Share	0.08

Full Cash Flow Statement

Margins

Gross margin is 33.60%, with operating and profit margins of -1.80% and -2.56%.

Gross Margin	33.60%
Operating Margin	-1.80%
Pretax Margin	-4.18%
Profit Margin	-2.56%
EBITDA Margin	0.82%
EBIT Margin	-1.80%
FCF Margin	12.42%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 4.39%.

Dividend Per Share	0.05
Dividend Yield	4.39%
Dividend Growth (YoY)	13.64%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.71%
Shareholder Yield	5.10%
Earnings Yield	-1.50%
FCF Yield	7.20%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Monash IVF Group has an Altman Z-Score of 1.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.18
Piotroski F-Score	n/a